Shares of Granules India Ltd crashed 4% on 9 September after the company announced receiving six observations from the US Food and Drug Administration (USFDA). ...
Lupin, the pharma major, has received six US FDA Form 483 observations for its Indore plant. The regulator has said that the observations included no...